| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 7 | -443K | 100% | $35.38 | -$15.7M |
| Net | -7 | -443K | -100% | -$15.7M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jack A. Khattar | President, CEO, Director | $70.7M | -$9.12M | -11.4% | Nov 8, 2024 |
| Charles W. Newhall III | Director | $4.72M | -$458K | -8.84% | Nov 11, 2024 |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | $2.63M | -$223K | -7.82% | Feb 23, 2024 |
| John M. Siebert | Director | $2.56M | Feb 23, 2024 | ||
| Frederick M. Hudson | Director | $1.03M | -$576K | -35.8% | Nov 8, 2024 |
| Carrolee Barlow | Director | $500K | Feb 23, 2024 | ||
| Georges Gemayel | Director | $483K | -$1.35M | -73.6% | Nov 8, 2024 |
| Frank Mottola | SVP, Quality, GMP, Ops, IT | $467K | -$555K | -54.3% | Nov 7, 2024 |
| Timothy C. Dec | Senior Vice-President & CFO | $427K | Feb 23, 2024 | ||
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | $395K | -$3.35M | -89.4% | Aug 20, 2024 |
| Jonathan Rubin | SVP, Chief Medical Officer | $244K | Feb 23, 2024 | ||
| Bethany Sensenig | Director | $150K | Feb 22, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|